The preparation and the tissue distribution of liposomal CPT-11

Drug Delivery System

Volumn 11, Issue 6, 1996, Pages 419-426

  Sadzuka, Yasuyuki ^a   Hirotsu, Sachiyo ^a   Miyagishima, Atsuo ^a   Nozawa, Yasuo ^a   Hirota, Sadao ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

CPT 11; liposome; polyethyleneglycol; prodrug; SN 38

Indexed keywords

EID: 85009579885     PISSN: 09135006     EISSN: 18812732     Source Type: Journal    
DOI: 10.2745/dds.11.419     Document Type: Article

References (15)

1. Sawada S, Okajima S, Aiyama R, Nokata K, Furuta T : Synthesis and antitumor activity of 20(s)-camptotecin derivatives : Carbamate-linked, water-soluble derivatives of 7-ethl-10 hydroxycamptothecin. Chem. Pharm. Bull. 39(6) : 1446-1454, 1991.
2. Tewey KM, Rowe TC, Yand L, Halligan BD, Liu LF : Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science (Wash. DC) 226 : 466-468, 1984.
3. Kawato Y, Aonuma M, Hirota Y, Kuga H, Sato K : Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res. 51(16) : 4187-4191, 1991.
4. Kawato Y, Furuta T, Aonuma M, Yokokura T, Matsumoto K : Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice. Cancer Chemother. Pharmacol. 28(3) : 192-198, 1991.
5. Kudoh S, Takada M, Masuda N, Nakagawa K, Itoh K : Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts. Jpn. J. Cancer Res. 84 : 203-207, 1993.
6. Nishimura G, Satou T, Yoshimitsu Y, Kurosaka Y, Fujimura T : Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer. Jpn. J. Cancer Chemother. 27(1) : 93-97, 1995.
7. Sadzuka Y, Nakai S, Miyagishima A, Nozawa Y, Hirota S : The effect of dose on the distribution of adriamycin encapsulated in polyethleneglycol-coated liposomes. J. Drug Targeting 3 : 31-37, 1995.
8. Hirotsu S, Sadzuka Y, Miyagishima A, Nozawa Y, Hirota S : The preparation and the tissue distribution of liposomal CPT-11. Drug Delivery System 10(4); 283, 1995.
9. Kawato Y, Aonuma M, Matsumoto K, Sato K : Production of SN-38, a main metabolite of the camptothecin derivative CPT-11, and its species and tissue specificities. Xenobio. Metabol. Dispos. 6 : 899-907, 1991.
10. Kono A, Hara Y : Conversion of CPT-11 into SN-38 in human tissues. Jpn. J. Cancer Chemother. 18(12) : 2175-2178, 1991.
11. Tsuji T, Kaneda N, Kado K, Tokokura T, Yoshimoto T : CPT-11 converting enzyme from rat serum : Purification and some properties. J. Pharmacobiodyn. 14(6) : 341-349, 1991.
12. Shimada K, Miyagishima A, Sadzuka Y, Nozawa Y, Hirota S : Determination of the thickness of fixed aqueous layer around the polyethleneglycol-coated liposomes. J. Drug Targeting 3 : 283-289, 1995.
13. Sadzuka Y, Hirotsu S, Miyagishima A, Nozawa Y, Hirota S : The study of polyethleneglycol-coated liposomes containing CPT-11. J. Liposome Research, (submitted).
14. Araki E, Ishikawa M, Iigo M, Koide T, Itabashi M : Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plama of athymic mice following intraperitoneal administration of CPT-11. Jpn. J. Cancer Res. 84 : 697-702, 1993.
15. Gupta E, Lestingi TM, Mick R, Ramirez J, Vokes EF, Ratain MJ : Metabolic fate of irinotecan in humans : Correlation of glucuronidation with diarrhea. Cancer Res. 54 : 3723-3725, 1994.